For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview
The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 million in 2019.
The Point-of-Care Infectious Disease Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Point-of-Care Infectious Disease Diagnostics/Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented into HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC, etc.
Breakdown by Application, Point-of-Care Infectious Disease Diagnostics/Testing has been segmented into Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Point-of-Care Infectious Disease Diagnostics/Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Point-of-Care Infectious Disease Diagnostics/Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point-of-Care Infectious Disease Diagnostics/Testing market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Point-of-Care Infectious Disease Diagnostics/Testing Market Share Analysis
Point-of-Care Infectious Disease Diagnostics/Testing competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Point-of-Care Infectious Disease Diagnostics/Testing revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point-of-Care Infectious Disease Diagnostics/Testing revenue and market share for each player covered in this report.
The major players covered in Point-of-Care Infectious Disease Diagnostics/Testing are: Abbott, Cardinal Health, Siemens Healthineers, Thermo Fisher Scientific Inc, Trinity Biotech, F. Hoffmann-La Roche Ltd, Bio-Rad Labs Inc., Chembio Diagnostics Inc., BD & Company, Quest Diagnostics Inc., OJ-Bio Ltd., bioMérieux SA, Ortho-Clinical Diagnostics, Trivitron Healthcare, Sight Diagnostics Ltd., Gene POC, etc. Among other players domestic and global, Point-of-Care Infectious Disease Diagnostics/Testing market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
- Abbott
- Cardinal Health
- Siemens Healthineers
- Thermo Fisher Scientific Inc
- Trinity Biotech
- F. Hoffmann-La Roche Ltd
- Bio-Rad Labs Inc.
- Chembio Diagnostics Inc.
- BD & Company
- Quest Diagnostics Inc.
- OJ-Bio Ltd.
- bioMérieux SA
- Ortho-Clinical Diagnostics
- Trivitron Healthcare
- Sight Diagnostics Ltd.
- Gene POC
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina)
- MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- Other Infectious Disease POC
Market segment by Application, can be divided into
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others